BBVA USA’s ResMed RMD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$171K	Hold	648	–	–	0.01%	459
2021 Q2	$160K	Buy	+648	New	+$136K	0.01%	495

Other funds holding RMD

BBVA USA held its ResMed (RMD) position steady in Q3 2021 at 648 shares worth $171K. The position accounts for 0.01% of the portfolio, ranked #459.

BBVA USA first reported a position in RMD in Q2 2021 and has held it in 2 quarters since. 686 funds tracked by Wall St. Rank hold RMD as of Q3 2021.

BBVA USA held 648 shares of ResMed worth $171K as of Q3 2021.
BBVA USA left its ResMed share count unchanged in Q3 2021.
ResMed made up 0.01% of BBVA USA's portfolio in Q3 2021, its #459 holding.
BBVA USA first reported a position in ResMed in Q2 2021 and has held it in 2 quarters since.
686 funds tracked by Wall St. Rank held ResMed as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.